by admin | Apr 19, 2024 | Article
Dr. Ann Clarke, University of Calgary, Calgary, Alberta Dr. Susan J. Elliott, University of Waterloo, Waterloo, Ontario Dr. Francesca S. Cardwell, University of Waterloo, Waterloo, Ontario Principal: Dr. Ann Clarke Team members: Dr. Susan Elliott, Dr. Francesca...
by admin | Apr 19, 2024 | Article
Dr. Joyce Rauch, Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec Principal: Dr. Joyce Rauch Team members: Céleste Pilon, Elena Lonina, Dr. Jerrold S. Levine, Dr. Maziar Divangahi, Dr. Ciriaco Piccirillo, Dr. Jose A....
by admin | Apr 19, 2024 | Article
Vaccination records or receipts are issued by your province or territory. Current COVID-19 vaccination documents aren’t standardized for international travel. Some provinces and territories have created a secure proof of vaccination document for non-essential services...
by admin | Apr 19, 2024 | Article
Dr. Murray Urowitz, University Health Network, Toronto, Ontario Principal: Dr. Murray Urowitz Team members: Dr. Dafna Gladman, Dr. Zahi Touma, Dr. Konstantinos Tselios, Dr. Jiandong Su A major goal of clinical research in lupus is to improve disease management based...
by admin | Apr 19, 2024 | Article
Please visit https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/statement-september-10-2021-additional-dose-covid-19-vaccine-immunocompromised-following-1-2-dose-series.html for details.
by admin | Apr 19, 2024 | Article
If you’re moderately to severely immunocompromised due to disease or treatment, you may have a lower immune response to COVID-19 vaccination. NACI recommends you get an additional mRNA vaccine dose following your 1- or 2-dose vaccine series. The additional dose should...
